Genomics
Experience sharing is critical for women in science
Sharing experiences with future generations is key to moving science and biotechnology forward. As a female leader of a biotechnology company, Dr. Bridget Martell, CEO of Artizan Biosciences, shares her experiences and perspectives with ScienceBoard. Read More
Flexibility is key for automated flow cytometry workflows
A tutorial titled "Handling Large Data Sets Generated by Flow Cytometry in an Automated Environment" presented by Bio-Rad at the Society for Laboratory Automation and Screening 2022 International Conference and Expo demonstrated the flexibility and power of the company's flow cytometry workflow, from reagents and instrumentation to automation and data analysis. Read More
Focus on drug-manufacturing optimization prioritizes patient health
As medical innovations and therapeutics advance rapidly and dramatically increase in scale, there is a critical need for manufacturing processes that can keep up with this pace. This often calls for updates, overhauls, and collaboration among companies to maintain such a high standard of production. Read More
Funding for cell and gene therapies exceeded $70B in 2021
Total funding from all sources for cell and gene therapy companies totaled $70.8 billion last year, according to the recent “Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments” report published by Kalorama Information, a sister company of ScienceBoard. Read More
Dotmatics leader shares insights on the future of life science informatics
Robert Brown, vice president worldwide presales at Dotmatics, shares his experiences at the Society for Laboratory Automation and Screening (SLAS) 2022 International Conference and Expo with ScienceBoard. Read More
Giving a voice to professionals of color is important in the life sciences
Creating an environment where professionals of color feel empowered to use their voice and confidence that they will be heard is critical to business success, according to Pratt Wiley, CEO of The Partnership. He spoke with ScienceBoard about some of the important work the organization is leading to support diversity, equity, and inclusion in the workplace. Read More
Scientists improve ADC development with mix of experimental, computational tools
BOSTON -- Greg Thurber, PhD, professor at the University of Michigan explained how his lab is jointly using both experimental animal models and computational models to improve the overall speed and efficiency of drug development of antibody-drug conjugates (ADCs) to get more of the agents on the market. Thurber presented in a scientific session at the Society for Laboratory Automation and Screening (SLAS) 2022 International Conference and Expo. Read More
Step toward broader treatment for Duchenne muscular dystrophy
Current therapies to treat Duchenne muscular dystrophy, a genetic muscle-wasting disease, only work in a small proportion of people with the condition. Research published on February 21 in the Proceedings of the National Academy of Science provides a proof of concept for developing a therapy that could work for almost half of the people affected. Read More
Nucleosomes dictate the histone code
The histone code concept needs to be redefined at the nucleosomal level, according to Michael-Christopher Keogh, PhD, chief scientific officer of EpiCypher. During a live webinar, Keogh shared information about the tools that are required to critically re-evaluate the genomic distribution and regulatory function(s) of histone post-translational modification (PTMs). Read More
How one company is helping make complex medicines safer
Often, the most dangerous things in life are things that the human eye cannot see. This is true even for life-saving medicines. One company was founded to help the industry find these hidden particles and solve a key challenge in the development of complex drug products. Halo Labs’ CEO Rick Gordon spoke with ScienceBoard about how its low volume approach is providing a critical service for the drug development industry. Read More
Conferences
Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter